Drug Class: Benzodiazepine + Anticholinergic Antispasmodic Combination | Form: Oral Capsule | Prescription Status: Prescription Only (Rx) — Controlled Substance
What Are Librax Capsules?
Librax is a prescription combination capsule containing Chlordiazepoxide Hydrochloride 5mg and Clidinium Bromide 2.5mg — two complementary medicines that address the neurological and muscular components of anxiety-related gastrointestinal disorders simultaneously in a single capsule. Chlordiazepoxide is a benzodiazepine anxiolytic that reduces the central nervous system hypersensitivity and anxiety that drives and amplifies gastrointestinal symptoms in conditions such as irritable bowel syndrome and stress-related peptic disease. Clidinium Bromide is a quaternary ammonium anticholinergic antispasmodic that directly relaxes smooth muscle spasm in the gastrointestinal tract and reduces gastric acid secretion — addressing the peripheral gut dysfunction independently of the central anxiety component.
The rationale for this combination reflects the well-established gut-brain connection — the bidirectional neurological relationship between psychological state and gastrointestinal function. In IBS, peptic ulcer disease, and functional gastrointestinal disorders, anxiety and psychological stress directly worsen gut motility, increase acid secretion, and lower the visceral pain threshold — while gut symptoms simultaneously worsen anxiety, creating a self-reinforcing cycle. Librax breaks this cycle at both ends simultaneously — the Chlordiazepoxide component interrupts the central anxiety driving gut hypersensitivity while the Clidinium component directly reduces the gut spasm, hypermotility, and acid hypersecretion that the anxiety perpetuates.
Librax is a controlled substance due to the benzodiazepine component — it carries dependency risk with prolonged use and must only be used under close medical supervision for short-term treatment.
What Are Librax Capsules Used For?
Librax is prescribed as adjunctive therapy for:
- Irritable Bowel Syndrome (IBS — آنت کی تکلیف) — functional bowel disorder characterised by abdominal pain, cramping, bloating, and altered bowel habits where anxiety and smooth muscle hypermotility are both contributing factors
- Peptic ulcer disease (معدے کا السر) — gastric and duodenal ulcers where excess cholinergic stimulation drives acid hypersecretion and where anxiety significantly worsens symptom burden alongside primary ulcer treatment
- Acute enterocolitis — inflammatory bowel conditions with significant spasm, cramping, and motility dysfunction causing acute gastrointestinal distress
- Functional gastrointestinal disorders — anxiety-related gastrointestinal conditions including functional dyspepsia and stress-induced abdominal pain where the gut-brain axis dysregulation is central to symptom generation
- Spastic colon — colonic smooth muscle hyperspasm causing severe cramping, urgency, and altered bowel habits
- Pre-procedure gastrointestinal anxiety — short-term relief of gastrointestinal symptoms significantly worsened by anticipatory anxiety before medical procedures
Librax is adjunctive therapy — it is not a primary treatment for peptic ulcer disease (which requires specific anti-ulcer medicines such as PPIs or H2 blockers) but reduces symptoms and acid hypersecretion as a complementary component of a broader treatment plan.
How Do Librax Capsules Work?
Chlordiazepoxide HCl 5mg — Central Anxiolytic and Gut-Brain Axis Modulator: Chlordiazepoxide belongs to the benzodiazepine class — medicines that enhance the effect of GABA (gamma-aminobutyric acid), the brain's primary inhibitory neurotransmitter. By binding to GABA-A receptors and increasing the frequency of chloride ion channel opening, Chlordiazepoxide enhances GABAergic inhibition throughout the central nervous system — producing anxiolytic, sedative, muscle-relaxant, and anticonvulsant effects.
In the context of gastrointestinal disorders, the anxiolytic action of Chlordiazepoxide is particularly important through two complementary pathways. First, it reduces the central anxiety that directly stimulates the autonomic nervous system — decreasing the cholinergic overdrive that causes gastric acid hypersecretion, bowel hypermotility, and visceral hypersensitivity. Second, it reduces the central nervous system's amplification of gut pain signals — raising the visceral pain threshold and decreasing the intensity of abdominal pain and discomfort perceived by the patient. By calming the psychological component of gut-brain axis dysregulation, Chlordiazepoxide addresses the neurological root of anxiety-related gastrointestinal symptoms rather than merely suppressing peripheral gut manifestations.
Clidinium Bromide 2.5mg — Peripheral Anticholinergic Antispasmodic: Clidinium Bromide is a quaternary ammonium anticholinergic compound — it blocks muscarinic acetylcholine receptors throughout the gastrointestinal tract, reducing the excessive cholinergic stimulation that drives the gut smooth muscle hyperspasm, hypermotility, and acid hypersecretion of IBS, peptic ulcer disease, and functional bowel disorders.
By blocking muscarinic M1 receptors on gastric parietal cells, Clidinium reduces gastric acid secretion — decreasing the acid load that irritates ulcerated or inflamed gastric and duodenal mucosa. By blocking muscarinic receptors on gastrointestinal smooth muscle cells, it reduces the frequency and intensity of intestinal peristaltic contractions — relieving the cramping, urgency, and pain of bowel spasm. Because Clidinium is a quaternary ammonium compound, it carries an ionic charge that significantly limits its ability to cross the blood-brain barrier — meaning its anticholinergic effects are predominantly peripheral, targeting the gut directly while minimising central anticholinergic side effects such as confusion and cognitive impairment that can occur with tertiary anticholinergic drugs.
Why the Combination Works Better Than Either Drug Alone: Chlordiazepoxide addresses the central anxiety and autonomic nervous system overdrive that causes and perpetuates gut dysfunction. Clidinium addresses the peripheral gut smooth muscle spasm and acid hypersecretion that these central signals produce. Together they interrupt the gut-brain dysfunction cycle at two levels simultaneously — producing more comprehensive symptom relief than targeting either the central or peripheral component alone.
Dosage and Administration
⚠️ Use at the lowest effective dose for the shortest time necessary — Chlordiazepoxide is a benzodiazepine with dependence potential. Never stop suddenly after prolonged use — gradual tapering under medical supervision is required to avoid withdrawal. Do not drive or operate machinery while taking Librax — sedation and impaired reflexes are significant risks. Do not consume alcohol during treatment.
| Indication | Dose | Frequency | Duration |
|---|---|---|---|
| IBS / functional bowel disorders | 1 – 2 capsules | 3 – 4 times daily before meals and at bedtime | Short-term — as directed by doctor |
| Peptic ulcer (adjunctive) | 1 – 2 capsules | 3 – 4 times daily before meals and at bedtime | As part of broader ulcer treatment plan |
| Acute enterocolitis | 1 – 2 capsules | 3 – 4 times daily | Short-term acute management |
| Elderly patients | 1 capsule | Twice daily — increase cautiously if needed | Lower dose; close monitoring |
How to Take:
- Swallow the capsule whole with a full glass of water
- Take 30 to 45 minutes before meals and at bedtime — the anticholinergic Clidinium component acts most effectively when taken before food
- Take at consistent times each day to maintain stable drug levels
- Do not take more than prescribed — benzodiazepine dose escalation is a dependency risk
- Never stop suddenly after more than 2 weeks of use — always taper under doctor's guidance
Active Ingredients
| Ingredient | Strength per Capsule | Drug Class | Mechanism |
|---|---|---|---|
| Chlordiazepoxide Hydrochloride | 5mg | Benzodiazepine Anxiolytic | Enhances GABA inhibition — reduces central anxiety and autonomic gut hyperstimulation |
| Clidinium Bromide | 2.5mg | Quaternary Anticholinergic | Blocks muscarinic receptors — reduces gut smooth muscle spasm and gastric acid secretion |
Who Should NOT Take Librax Capsules?
Do not take Librax if you:
- Have glaucoma — particularly narrow-angle glaucoma; Clidinium's anticholinergic action increases intraocular pressure and can precipitate acute angle-closure glaucoma — a medical emergency
- Have benign prostatic hyperplasia (BPH) or urinary obstruction — anticholinergic drugs cause urinary retention, which can precipitate acute urinary retention in men with enlarged prostate
- Have myasthenia gravis — anticholinergic drugs severely worsen neuromuscular transmission in myasthenia gravis
- Have severe liver disease — Chlordiazepoxide metabolism is significantly impaired
- Have a history of benzodiazepine dependence or substance abuse
- Have respiratory depression or severe COPD — benzodiazepines suppress respiratory drive
- Are pregnant — benzodiazepines cause neonatal withdrawal and floppy infant syndrome; Clidinium passes into breast milk
- Are breastfeeding — both components pass into breast milk
- Are under 18 years of age
- Are allergic to Chlordiazepoxide, Clidinium, other benzodiazepines, or any ingredient
Always consult your doctor before use if you:
- Are elderly — significantly higher risk of sedation, falls, confusion, and urinary retention
- Have kidney impairment — reduced drug clearance increases accumulation risk
- Have sleep apnoea — benzodiazepines worsen upper airway obstruction during sleep
- Have a history of depression — benzodiazepines can worsen depression with prolonged use
- Are taking any CNS depressants — additive sedation risk
Side Effects
Common:
- Drowsiness and sedation — most common Chlordiazepoxide effect; impairs driving and machinery operation — do not drive while taking Librax
- Dry mouth (منہ کا خشک ہونا) — Clidinium anticholinergic effect; maintain good hydration and oral hygiene
- Constipation — anticholinergic reduction of gut motility; increase dietary fibre and fluid intake
- Blurred vision — anticholinergic effect on the ciliary muscle of the eye; usually transient
- Dizziness or lightheadedness — particularly on standing in elderly patients
- Urinary hesitancy or reduced urine flow — anticholinergic effect on bladder detrusor muscle
- Mild confusion or memory impairment — particularly in elderly patients; report to doctor
Serious — Stop Use and Seek Medical Attention Immediately:
- Acute angle-closure glaucoma — sudden severe eye pain, blurred vision, halos around lights, nausea — Clidinium-induced increase in intraocular pressure (یہ طبی ہنگامی صورتحال ہے)
- Acute urinary retention — sudden inability to urinate with painful bladder distension — particularly in men with prostate enlargement (یہ طبی ہنگامی صورتحال ہے)
- Severe respiratory depression — dangerously slow or shallow breathing — risk increased with alcohol, opioids, or other CNS depressants (یہ طبی ہنگامی صورتحال ہے)
- Paradoxical reactions — agitation, aggression, hostility, or increased anxiety — more common in elderly patients and those with psychiatric history; stop and seek medical advice
- Benzodiazepine withdrawal on abrupt discontinuation — severe anxiety, tremor, sweating, insomnia, seizures — medical emergency if severe; never stop suddenly after prolonged use (یہ طبی ہنگامی صورتحال ہے)
- Severe allergic reaction — rash, swelling of face or throat, difficulty breathing (یہ طبی ہنگامی صورتحال ہے)
Drug Interactions
| Medicine / Substance | Possible Interaction |
|---|---|
| Alcohol (شراب) | Severe additive CNS and respiratory depression — potentially fatal combination; strictly avoid |
| Opioid analgesics (Tramadol, Codeine, Morphine) | Dangerous additive respiratory depression and CNS depression — fatal combination risk; avoid |
| Other benzodiazepines or sedatives | Additive CNS and respiratory depression — avoid combination |
| Antidepressants (TCAs, SSRIs) | Additive sedation; TCAs also add anticholinergic effects — increased dry mouth, constipation, urinary retention |
| Antipsychotics (Haloperidol, Chlorpromazine) | Additive sedation and anticholinergic effects — increased confusion and urinary retention risk |
| Antihistamines (Chlorpheniramine, Promethazine) | Additive sedation and anticholinergic effects |
| Antifungals (Ketoconazole, Itraconazole) | Inhibit Chlordiazepoxide metabolism — increase plasma levels and sedation risk |
| Rifampicin | Accelerates Chlordiazepoxide metabolism — reduces plasma levels and anxiolytic effectiveness |
| Antacids | May reduce absorption of Clidinium component — take Librax 1 hour before antacids |
| Levodopa (Parkinson's medication) | Clidinium's anticholinergic action may reduce Levodopa effectiveness |
| Digoxin | Reduced gut motility from Clidinium may increase Digoxin absorption — monitor Digoxin levels |
Storage Instructions
- Store below 25°C in a cool, dry place
- Protect from moisture and direct sunlight
- Keep in original container — controlled substance requiring secure storage
- Keep out of reach of children and persons with history of substance misuse (بچوں کی پہنچ سے دور رکھیں)
- Do not use after the expiry date on the pack or carton
Frequently Asked Questions
Why does a gut condition like IBS need an anti-anxiety medicine like Chlordiazepoxide?
This is one of the most important questions about Librax. The gut and brain are connected through a bidirectional network called the gut-brain axis — involving the autonomic nervous system, the enteric nervous system of the gut, and a constant chemical signalling system between the two. Anxiety directly activates the sympathetic and parasympathetic nervous systems in ways that increase gastric acid secretion, accelerate or dysregulate bowel motility, heighten visceral pain sensitivity, and trigger smooth muscle spasm. In IBS and functional gastrointestinal disorders, this gut-brain dysregulation is the primary driver of symptoms — the gut itself is structurally normal but neurologically dysregulated. Chlordiazepoxide addresses the central anxiety component of this dysregulation — reducing the neurological input that perpetuates gut dysfunction — while Clidinium addresses the peripheral gut manifestations that this anxiety has produced.
Is Librax habit-forming — what is the risk of dependence?
Yes — Librax carries a genuine dependence risk because of its Chlordiazepoxide content. Benzodiazepines including Chlordiazepoxide cause physical dependence with regular use — the brain adapts to the enhanced GABA inhibition they produce, and when the drug is reduced or stopped, the absence of this inhibition causes rebound CNS excitation manifesting as anxiety, insomnia, tremor, sweating, and in severe cases — seizures. This dependence can develop within 2 to 4 weeks of daily use. Librax should therefore be used at the lowest effective dose and for the shortest duration necessary — typically no more than 2 to 4 weeks of continuous use. Never stop Librax abruptly after more than 2 weeks of daily use — always taper the dose gradually under your doctor's supervision to allow the brain to readjust safely.
Why must Librax be taken before meals — does the timing matter?
Timing matters specifically because of the Clidinium Bromide component. Clidinium reduces gastric acid secretion and slows gastrointestinal motility through its anticholinergic action — effects that are most useful when they are active during and after a meal when food-stimulated acid secretion and post-meal bowel motility are at their peak. Taking Librax 30 to 45 minutes before a meal ensures that therapeutic Clidinium concentrations are present in the gut at the time of maximum post-meal acid and motility stimulation — optimising its protective and antispasmodic effect during the meal period when symptoms are typically worst. Taking it after meals significantly reduces this timing advantage.
Can Librax cause urinary problems — who is most at risk?
Urinary hesitancy and reduced urinary flow are recognised anticholinergic side effects of Clidinium Bromide. The bladder detrusor muscle contracts under cholinergic stimulation to empty the bladder — blocking these signals reduces bladder contractility, making urination slower and more effortful. In healthy patients, this mild effect is usually not clinically significant. However, in men with benign prostatic hyperplasia (enlarged prostate) — where urinary flow is already partially obstructed by the enlarged gland — adding Clidinium's detrusor-relaxing effect can push the bladder into acute urinary retention — a painful inability to urinate requiring emergency catheterisation. Librax is therefore contraindicated in men with significant prostate enlargement or any degree of urinary obstruction. Men should inform their doctor of any urinary symptoms before starting Librax.
Can Librax be used long-term for chronic IBS?
Long-term daily use of Librax is not recommended due to the benzodiazepine dependence risk of the Chlordiazepoxide component. For chronic IBS requiring ongoing pharmacological management, alternative approaches with better long-term safety profiles are more appropriate — including antispasmodics without benzodiazepine components such as Mebeverine or Phloroglucinol for gut spasm, low-dose tricyclic antidepressants for gut-brain axis modulation, specific IBS medicines, and psychological interventions such as cognitive behavioural therapy for the anxiety component. Librax is most appropriately used for short-term management of acute flares — particularly when anxiety and gut symptoms are simultaneously severe — rather than as a maintenance daily treatment.
⚕️ Medical Disclaimer: This product description is for general informational purposes only and does not replace professional medical advice. Librax is a controlled prescription medication containing a benzodiazepine — always use under close supervision of a qualified doctor. Do not drive while taking Librax. Never combine with alcohol or opioids. Never stop suddenly after prolonged use — always taper under medical supervision. If you experience acute eye pain, inability to urinate, or severe breathing difficulty, seek emergency medical attention immediately.
Prescription Required (Rx) — Controlled Substance | Do Not Drive | Never Combine With Alcohol | Take Before Meals | Short-Term Use Only | Never Stop Suddenly — Always Taper
